March 23, 2018 / 12:19 PM / 7 months ago

BRIEF-Nuvo Pharmaceuticals Reports Q4 Revenue Of C$4.5 Million

March 23 (Reuters) - Nuvo Pharmaceuticals Inc:

* NUVO PHARMACEUTICALS™ ANNOUNCES 2017 FOURTH QUARTER AND YEAR-END RESULTS

* Q4 REVENUE C$4.5 MILLION VERSUS C$5.6 MILLION

* QTRLY ‍ TOTAL REVENUE WAS $4.5 MILLION COMPARED TO $5.6 MILLION​

* QTRLY ‍NET LOSS FROM CONTINUING OPERATIONS WAS $0.2 MILLION VERSUS NET INCOME FROM CONTINUING OPERATIONS OF $1.7 MILLION​

* ‍CASH AND SHORT-TERM INVESTMENTS WERE $10.4 MILLION AS AT DECEMBER 31, 2017 COMPARED TO $17.7 MILLION AS AT SEPTEMBER 30, 2017​

* NUVO PHARMACEUTICALS - ‍NOT YET SEEN SIGNIFICANT NEGATIVE EFFECT FROM HORIZON’S SALES FORCE REDUCTION THAT MIGHT IMPACT BOTTLE ORDERING PATTERNS

* ‍REDUCTION IN SAMPLE PRODUCT ORDERS FROM HORIZON HAD A NEGATIVE IMPACT ON COMPANY’S 2017 FINANCIAL RESULTS​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below